Trial Profile
A Randomized Controlled Study of Docetaxel Monotherapy or DOXIL/CAELYX and Docetaxel for the Treatment of Advanced Breast Cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Dec 2021
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Docetaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms DOXIL BCA
- Sponsors Janssen Research & Development
- 17 Aug 2009 Results published in JCO.
- 07 Jul 2009 Actual end date (1 Dec 2008) added as reported by ClinicalTrials.gov.
- 07 Jul 2009 Actual end date (1 Dec 2008) added as reported by ClinicalTrials.gov.